首页> 外国专利> MMSET AURKA Use for regulating cell proliferation and apoptosis by MMSET-mediated methylation of AURKA

MMSET AURKA Use for regulating cell proliferation and apoptosis by MMSET-mediated methylation of AURKA

机译:MMSET AURKA用于通过MMSET介导的AURKA甲基化调节细胞增殖和凋亡

摘要

The present invention relates to the use of MMSET-mediated AURKA methylation to regulate cell proliferation and apoptosis. MMSET/WHSC1 is highly expressed in several tumor types, and its expression has been shown to be involved in cell proliferation. The present inventors confirmed that MMSET binds to Aurora kinase A (AURKA) and methylates AURKA. The present inventors confirmed that MMSET-mediated methylation of AURKA induces binding to p53 and enhances the kinase activity of AURKA, which caused proteasome degradation of p53. MMSET-mediated p53 degradation increased cell proliferation and showed oncogenic activity. In addition, the knockout of MMSET strongly inhibited tumorigenic cells, and showed sensitivity to growth inhibition by the therapeutic drug alisertib (AURKA inhibitor). In conclusion, the present invention showed that in proliferating cells, MMSET modulates p53 stability through methylation of AURKA, and may be a potential therapeutic target in solid cancer.
机译:本发明涉及MMSET介导的AURKA甲基化在调节细胞增殖和凋亡中的用途。 MMSET / WHSC1在几种肿瘤类型中高度表达,并且已表明其表达与细胞增殖有关。本发明人证实了MMSET与Aurora激酶A(AURKA)结合并甲基化AURKA。本发明人证实了MMSET介导的AURKA的甲基化诱导与p53的结合并增强了AURKA的激酶活性,这引起了p53的蛋白酶体降解。 MMSET介导的p53降解增加细胞增殖并显示致癌活性。此外,敲除MMSET可以强烈抑制致瘤细胞,并显示出对治疗药物alisertib(AURKA抑制剂)抑制生长的敏感性。总之,本发明表明在增殖细胞中,MMSET通过AURKA的甲基化调节p53稳定性,并且可能是实体癌的潜在治疗靶标。

著录项

  • 公开/公告号KR102171355B1

    专利类型

  • 公开/公告日2020-10-28

    原文格式PDF

  • 申请/专利权人 중앙대학교 산학협력단;

    申请/专利号KR20190073667

  • 发明设计人 서상범;박진우;김지영;채윤철;

    申请日2019-06-20

  • 分类号C12N9/12;C12N9/10;C12Q1/6886;G01N33/53;G01N33/574;

  • 国家 KR

  • 入库时间 2022-08-21 11:03:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号